O Petitjean
Overview
Explore the profile of O Petitjean including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Bayat S, Louchahi K, Verdiere B, Anglade D, Rahoui A, Sorin P, et al.
Eur Respir J
. 2004 Aug;
24(1):150-6.
PMID: 15293618
The efficacy of antimicrobial agents against pulmonary infections depends on their local concentrations in the lung. The aims of the present study were to: 1) compare technetium-99m diethylenetriaminepenta-acetic acid (99mTc-DTPA)...
3.
Tod M, Padoin C, Petitjean O
Clin Pharmacokinet
. 2001 Dec;
40(11):803-14.
PMID: 11735603
Measurements of aminoglycoside concentration in serum are used to individualise dosage regimens (dose per administration and/or administration interval) with the goal of attaining the desired therapeutic range as quickly as...
4.
Mimoz O, SCHAEFFER V, Incagnoli P, Louchahi K, Edouard A, Petitjean O, et al.
Crit Care Med
. 2001 Jul;
29(7):1350-5.
PMID: 11445684
Objective: To determine the effects of severe trauma with hemorrhagic shock on amoxicillin and clavulanate concentrations in plasma and their pharmacokinetics. Design: A prospective, open, descriptive study. Setting: A 12-bed,...
5.
Bouley M, Briere C, Padoin C, Petitjean O, Tod M
Ther Drug Monit
. 2001 Feb;
23(1):56-60.
PMID: 11206045
A rapid, sensitive, and specific liquid chromatography method for the simultaneous determination of four protease inhibitors (indinavir, nelfinavir, ritonavir, and saquinavir) in human plasma is described. After a liquid-liquid extraction...
6.
Tod M, Lokiec F, Bidault R, De Bony F, Petitjean O, Aujard Y
Antimicrob Agents Chemother
. 2000 Dec;
45(1):150-7.
PMID: 11120958
Acyclovir is approved for the treatment of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections in children by the intravenous and oral routes. However, its use by the oral...
7.
Mimoz O, Soreda S, Padoin C, Tod M, Petitjean O, Benhamou D
Anesthesiology
. 2000 Sep;
93(3):735-43.
PMID: 10969307
Background: Although various drugs used by anesthesiologists highly bind to plasma proteins, the impact of iatrogenically induced hypoproteinemia on their pharmacologic effects has never been investigated. The authors determined the...
8.
Fauvelle F, Petitjean O, Tod M, Guillevin L
Therapie
. 2000 Sep;
55(2):269-75.
PMID: 10967699
Drug removal during plasma exchange (PE) is a complex phenomenon that is defined by the molecule pharmacokinetic characteristics. Plasma-protein binding and the volume of distribution (Vd) are two kinetic parameters...
9.
Tod M, Padoin C, Petitjean O
Clin Pharmacokinet
. 2000 Apr;
38(3):205-23.
PMID: 10749517
Isepamicin is an aminoglycoside antibacterial with properties similar to those of amikacin, but with better activity against strains producing type I 6'-acetyltransferase. The antibacterial spectrum includes Enterobacteriaceae and staphylococci. Anaerobes,...
10.
Mimoz O, Leotard S, Jacolot A, Padoin C, Louchahi K, Petitjean O, et al.
Antimicrob Agents Chemother
. 2000 Mar;
44(4):885-90.
PMID: 10722486
The antibacterial activities of imipenem-cilastatin, meropenem-cilastatin, cefepime and ceftazidime against Enterobacter cloacae NOR-1, which produces the carbapenem-hydrolyzing beta-lactamase NmcA and a cephalosporinase, and against one of its in vitro-obtained ceftazidime-resistant...